362 related articles for article (PubMed ID: 25855382)
1. PLK1 and HOTAIR Accelerate Proteasomal Degradation of SUZ12 and ZNF198 during Hepatitis B Virus-Induced Liver Carcinogenesis.
Zhang H; Diab A; Fan H; Mani SK; Hullinger R; Merle P; Andrisani O
Cancer Res; 2015 Jun; 75(11):2363-74. PubMed ID: 25855382
[TBL] [Abstract][Full Text] [Related]
2. Subset of Suz12/PRC2 target genes is activated during hepatitis B virus replication and liver carcinogenesis associated with HBV X protein.
Studach LL; Menne S; Cairo S; Buendia MA; Hullinger RL; Lefrançois L; Merle P; Andrisani OM
Hepatology; 2012 Oct; 56(4):1240-51. PubMed ID: 22505317
[TBL] [Abstract][Full Text] [Related]
3. Proteins ZNF198 and SUZ12 are down-regulated in hepatitis B virus (HBV) X protein-mediated hepatocyte transformation and in HBV replication.
Wang WH; Studach LL; Andrisani OM
Hepatology; 2011 Apr; 53(4):1137-47. PubMed ID: 21480320
[TBL] [Abstract][Full Text] [Related]
4. RNA helicase DEAD box protein 5 regulates Polycomb repressive complex 2/Hox transcript antisense intergenic RNA function in hepatitis B virus infection and hepatocarcinogenesis.
Zhang H; Xing Z; Mani SK; Bancel B; Durantel D; Zoulim F; Tran EJ; Merle P; Andrisani O
Hepatology; 2016 Oct; 64(4):1033-48. PubMed ID: 27338022
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2.
Fan H; Zhang H; Pascuzzi PE; Andrisani O
Oncogene; 2016 Feb; 35(6):715-26. PubMed ID: 25893293
[TBL] [Abstract][Full Text] [Related]
6. Deregulation of epigenetic mechanisms by the hepatitis B virus X protein in hepatocarcinogenesis.
Andrisani OM
Viruses; 2013 Mar; 5(3):858-72. PubMed ID: 23507839
[TBL] [Abstract][Full Text] [Related]
7. EpCAM-regulated intramembrane proteolysis induces a cancer stem cell-like gene signature in hepatitis B virus-infected hepatocytes.
Mani SK; Zhang H; Diab A; Pascuzzi PE; Lefrançois L; Fares N; Bancel B; Merle P; Andrisani O
J Hepatol; 2016 Nov; 65(5):888-898. PubMed ID: 27238755
[TBL] [Abstract][Full Text] [Related]
8. Polo-like kinase 1 inhibition suppresses hepatitis B virus X protein-induced transformation in an in vitro model of liver cancer progression.
Studach LL; Rakotomalala L; Wang WH; Hullinger RL; Cairo S; Buendia MA; Andrisani OM
Hepatology; 2009 Aug; 50(2):414-23. PubMed ID: 19472310
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
Li J; Dai X; Zhang H; Zhang W; Sun S; Gao T; Kou Z; Yu H; Guo Y; Du L; Jiang S; Zhang J; Zhou Y
Oncotarget; 2015 Oct; 6(30):29196-208. PubMed ID: 26470691
[TBL] [Abstract][Full Text] [Related]
10. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E
Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430
[TBL] [Abstract][Full Text] [Related]
11. Dynamic expression of ZNF382 and its tumor-suppressor role in hepatitis B virus-related hepatocellular carcinogenesis.
Dang S; Zhou J; Chen Y; Chen P; Ji M; Shi B; Yang Q; Hou P
Oncogene; 2019 Jun; 38(24):4804-4819. PubMed ID: 30804458
[TBL] [Abstract][Full Text] [Related]
12. ZNF198 stabilizes the LSD1-CoREST-HDAC1 complex on chromatin through its MYM-type zinc fingers.
Gocke CB; Yu H
PLoS One; 2008 Sep; 3(9):e3255. PubMed ID: 18806873
[TBL] [Abstract][Full Text] [Related]
13. Intrahepatic hepatitis B virus large surface antigen induces hepatocyte hyperploidy via failure of cytokinesis.
Li TN; Wu YJ; Tsai HW; Sun CP; Wu YH; Wu HL; Pei YN; Lu KY; Yen TT; Chang CW; Chan HL; Tao MH; Liou JY; Chang MD; Su IJ; Wang LH
J Pathol; 2018 Aug; 245(4):502-513. PubMed ID: 29862509
[TBL] [Abstract][Full Text] [Related]
14. The JAZF1-SUZ12 fusion protein disrupts PRC2 complexes and impairs chromatin repression during human endometrial stromal tumorogenesis.
Ma X; Wang J; Wang J; Ma CX; Gao X; Patriub V; Sklar JL
Oncotarget; 2017 Jan; 8(3):4062-4078. PubMed ID: 27845897
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity of PLK1-targeting siRNA delivered by lipid nanoparticles in HBV-infected hepatocytes.
Foca A; Dhillon A; Lahlali T; Lucifora J; Salvetti A; Rivoire M; Lee A; Durantel D
Antivir Ther; 2020; 25(3):151-162. PubMed ID: 32496211
[TBL] [Abstract][Full Text] [Related]
16. [Hepatitis B virus X protein-regulated expression of Plk1].
Tu J; Zhang T; Cheng J; Zeng ZZ; Lu FM; Chen XM
Zhonghua Gan Zang Bing Za Zhi; 2016 Jan; 24(1):46-50. PubMed ID: 26983389
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNAs in hepatitis B virus-related hepatocellular carcinoma.
Yu TT; Xu XM; Hu Y; Deng JJ; Ge W; Han NN; Zhang MX
World J Gastroenterol; 2015 Jun; 21(23):7208-17. PubMed ID: 26109807
[TBL] [Abstract][Full Text] [Related]
18. HBx drives alpha fetoprotein expression to promote initiation of liver cancer stem cells through activating PI3K/AKT signal pathway.
Zhu M; Li W; Lu Y; Dong X; Lin B; Chen Y; Zhang X; Guo J; Li M
Int J Cancer; 2017 Mar; 140(6):1346-1355. PubMed ID: 27925189
[TBL] [Abstract][Full Text] [Related]
19. LSD1 Inhibition Attenuates Tumor Growth by Disrupting PLK1 Mitotic Pathway.
Dalvi PS; Macheleidt IF; Lim SY; Meemboor S; Müller M; Eischeid-Scholz H; Schaefer SC; Buettner R; Klein S; Odenthal M
Mol Cancer Res; 2019 Jun; 17(6):1326-1337. PubMed ID: 30760542
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.
Xie Q; Chen L; Shan X; Shan X; Tang J; Zhou F; Chen Q; Quan H; Nie D; Zhang W; Huang AL; Tang N
Int J Cancer; 2014 Aug; 135(3):635-46. PubMed ID: 24374650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
